Tamer Abdelgawad

Tamer Abdelgawad

Pfizer Inc. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4543858
-
person_outline Tamer Abdelgawad's MOST POPULAR ARTICLES
1-) The large social value resulting from use of statins warrants steps to improve adherence and broaden treatmentDC Grabowski, DN Lakdawalla, DP Goldman, M Eber, LZ Liu, ...Health affairs 31 (10), 2276-2285, 2012652012
2-) New anticancer drugs associated with large increases in costs and life expectancyDH Howard, ME Chernew, T Abdelgawad, GL Smith, J Sollano, ...Health Affairs 35 (9), 1581-1587, 2016432016
3-) Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to MedicaidMM Murawski, T AbdelgawadAm J Manag Care 11 (special issue), SP35-SP42, 2005382005
4-) Preferred drug lists and Medicaid prescriptionsT Abdelgawad, L Egbuonu-DavisPharmacoeconomics 24, 55-63, 2006182006
5-) PCN402 the clinical and economic consequences of delays in reimbursement for select novel cancer therapeutics in Canada, Italy, and AustraliaB Leinwand, J Sollano, JP Doherty, G Smith, F Ali, M Johnsrud, ...Value in Health 22, S514, 201922019